Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.

Kim NH, Lim HY, Im KS, Shin JI, Kim HW, Sur JH.

J Comp Pathol. 2014 Jul;151(1):42-50. doi: 10.1016/j.jcpa.2014.04.001. Epub 2014 Jun 6.

PMID:
24913515
2.

Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.

Mainenti M, Rasotto R, Carnier P, Zappulli V.

Vet J. 2014 Oct;202(1):62-8. doi: 10.1016/j.tvjl.2014.06.003. Epub 2014 Jun 11.

PMID:
24980810
3.

Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.

Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I, Poli A.

Res Vet Sci. 2005 Dec;79(3):225-32. Epub 2005 Apr 7.

PMID:
16054892
4.

Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.

Kim NH, Lim HY, Im KS, Kim JH, Sur JH.

J Comp Pathol. 2013 May;148(4):298-306. doi: 10.1016/j.jcpa.2012.08.009. Epub 2012 Oct 15.

PMID:
23079102
5.

Expression and prognostic significance of CK19 in canine malignant mammary tumours.

Gama A, Alves A, Schmitt F.

Vet J. 2010 Apr;184(1):45-51. doi: 10.1016/j.tvjl.2009.02.001. Epub 2009 Mar 4.

PMID:
19264518
6.

Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.

Guil-Luna S, Stenvang J, Brünner N, Sánchez-Céspedes R, Millán Y, Gómez-Laguna J, de las Mulas JM.

Vet Pathol. 2014 Sep;51(5):895-902. doi: 10.1177/0300985813511127. Epub 2013 Nov 18.

PMID:
24249219
7.

Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.

Sinn BV, Darb-Esfahani S, Wirtz RM, Budczies J, Sehouli J, Chekerov R, Dietel M, Denkert C.

Histopathology. 2011 Nov;59(5):918-27. doi: 10.1111/j.1365-2559.2011.04028.x.

PMID:
22092403
8.

Evaluation of FOXP3 expression in canine mammary gland tumours.

Oh SY, Ryu HH, Yoo DY, Hwang IK, Kweon OK, Kim WH.

Vet Comp Oncol. 2014 Mar;12(1):20-8. doi: 10.1111/j.1476-5829.2012.00327.x. Epub 2012 Apr 27.

PMID:
22541038
9.

Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.

Donnay I, Rauïs J, Wouters-Ballman P, Devleeschouwer N, Leclercq G, Verstegen JP.

J Reprod Fertil Suppl. 1993;47:501-12.

PMID:
8229969
10.

Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.

Martín de las Mulas J, Van Niel M, Millán Y, Ordás J, Blankenstein MA, Van Mil F, Misdorp W.

Res Vet Sci. 2002 Apr;72(2):153-61.

PMID:
12027597
11.
12.

Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.

Boldizsár H, Muray T, Számel I, Szenci O, Csenki J.

Acta Vet Hung. 1992;40(1-2):89-97.

PMID:
1476094
13.

Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases.

Peña L, Perez-Alenza MD, Rodriguez-Bertos A, Nieto A.

Breast Cancer Res Treat. 2003 Mar;78(2):141-8.

PMID:
12725414
14.

Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.

Morris JS, Nixon C, King OJ, Morgan IM, Philbey AW.

Vet J. 2009 Mar;179(3):422-9. doi: 10.1016/j.tvjl.2007.10.025. Epub 2008 Mar 7.

PMID:
18314357
15.

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.

PMID:
18668363
16.

Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.

Chang CC, Tsai MH, Liao JW, Chan JP, Wong ML, Chang SC.

J Am Vet Med Assoc. 2009 Aug 15;235(4):391-6. doi: 10.2460/javma.235.4.391.

PMID:
19681719
17.

Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland.

Lantinga-van Leeuwen IS, van Garderen E, Rutteman GR, Mol JA.

J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):219-28.

PMID:
11282275
18.

Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance.

Millanta F, Calandrella M, Vannozzi I, Poli A.

Vet Rec. 2006 Jun 17;158(24):821-4.

PMID:
16782855
20.

Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.

Thuróczy J, Reisvaag GJ, Perge E, Tibold A, Szilágyi J, Balogh L.

J Comp Pathol. 2007 Aug-Oct;137(2-3):122-9. Epub 2007 Jul 23.

PMID:
17645888

Supplemental Content

Support Center